New Year. New Century. New Wishes.

(Paris:PUB), New Year. New Century. New Wishes. Groupe brings its past to life with AI and innovation, to celebrate its first century and set a course for the next December 04, 2025 – Paris – Publicis Groupe [Euronext Paris FR0000130577, CAC 40] From its beginnings in 1926 as a creative hot shop in Montmartre, to […]

ScanTech AI Systems Inc. Initiates Appeal Process with Nasdaq; Automatic Stay Provided

ScanTech AI Systems Inc. Initiates Appeal Process with Nasdaq; Automatic Stay Provided GlobeNewswire December 04, 2025 Atlanta, GA, Dec. 04, 2025 (GLOBE NEWSWIRE) — ScanTech AI Systems Inc. (the “Company” or “ScanTech AI”) (Nasdaq: STAI), a developer of advanced AI-powered security screening and imaging systems, today announced that following the previously disclosed timely Nasdaq Hearings

AmpliTech Group To Hold Its Annual Shareholder Meeting And Showcase Its ORAN 5G Network Performance To Attendees

AmpliTech Group To Hold Its Annual Shareholder Meeting And Showcase Its ORAN 5G Network Performance To Attendees GlobeNewswire December 04, 2025 HAUPPAUGE, N.Y., Dec. 04, 2025 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (“AmpliTech” or the “Company”) today announced that during its annual shareholder meeting, it will host an Investor Demo Day on December 10, 2025,

American Rebel Holdings, Inc. (NASDAQ: AREB) Secures Third Pennsylvania Distributor as Mid-State Beverage Company Supercharges White-Hot American Rebel Light Beer National Distribution Rollout

American Rebel Holdings, Inc. (NASDAQ: AREB) Secures Third Pennsylvania Distributor as Mid-State Beverage Company Supercharges White-Hot American Rebel Light Beer National Distribution Rollout GlobeNewswire December 04, 2025 Award-winning Molson Coors wholesaler, Mid-State with 50+ year legacy, 12-county footprint and 6-day-a-week coverage adds major scale in central and northern Pennsylvania for American Rebel Light Beer Mid-State

Genvor to Present at the Life Sciences Virtual Investor Forum December 11th

Genvor to Present at the Life Sciences Virtual Investor Forum December 11th Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com GlobeNewswire December 04, 2025 WOODLAND, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) — Genvor, Inc. (OTCQB: GNVR), a pioneer in AI-accelerated peptide technology for sustainable agriculture, today

Bravident Extends Holiday Sale as Demand Surges for Its Walk Adventure Kit Deals to Help Dog Owners Finally Say Goodbye to Chaotic Walks

Bravident Extends Holiday Sale as Demand Surges for Its Walk Adventure Kit Deals to Help Dog Owners Finally Say Goodbye to Chaotic Walks GlobeNewswire December 04, 2025 NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) — With nearly 68 million dog-owning households in the U.S., everyday walks often come with real frustrations–tangled leashes, too many items

Remedy Plan Therapeutics to Present Results from Phase 1 Healthy Volunteer Study of NAMPT Inhibitor RPT1G and Other Progress at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition

Remedy Plan Therapeutics to Present Results from Phase 1 Healthy Volunteer Study of NAMPT Inhibitor RPT1G and Other Progress at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition GlobeNewswire December 04, 2025 NAMPT inhibitor RPT1G demonstrated favorable safety and significant target engagement in first-in-human study Company to present Trial in Progress design

Firefly Aerospace Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – FLY

Firefly Aerospace Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – FLY GlobeNewswire December 04, 2025 LOS ANGELES, Dec. 04, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against Firefly Aerospace Inc. (“Firefly” or “the Company”) (NASDAQ: FLY) for violations

Ajax Therapeutics Presents Preclinical Data on Differentiated Efficacy Profile of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the American Society of Hematology Annual Meeting

Ajax Therapeutics Presents Preclinical Data on Differentiated Efficacy Profile of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the American Society of Hematology Annual Meeting GlobeNewswire December 04, 2025 – Data demonstrate superior efficacy compared to ruxolitinib, an approved type I JAK2 inhibitor, including reductions in mutant allele burden and bone marrow fibrosis, key markers

Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS)

Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS) GlobeNewswire December 04, 2025 Featured article strengthens growing body of clinical evidence for Nociscan by highlighting a successful case study Special Pain issue features breakthrough innovations shaping the future of spine care IJSS publishes over 150 articles

Scroll to Top